"CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds," Hargrove, T.; Kim, K.; Soeiro, M.; Silva, C.; Batista, D.; Batista, M.; Yazlovitskaya, E.; Waterman, M.; Sulikowski, G. A.; Lepesheva, G. Drugs and Drug Resistance 2012, 2 , 178.

"Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: Development of a highly selective and more potent in vitro probe," E. Delphire, A. Baranczak, Waterson, A.; Kim, K.; Kett, N.; Morrison, R.; Scott, D.; J.; Weaver, D.; . Lindsley, C. W. Bioorganic & Medicinal Chemistry Letters  2012, 22,14, 4532.

"Allosteric Antagonism of Insect Odarant Receptor Ion Channels" P. L. Jones., G. M. Pask., I. M. Romaine., R. W. Taylor., P. R. Reid., A. G. Waterson., G. A. Sulikowski., L. J. Zwiebel, PLoS ONE, 2012, 7, e30304.

"Discovering Small Molecules that Promote Cardiomyocyte Generation by Modulating Wnt Signaling” T. Ni, E. J. Rellinger, A. Mukherjee, S. Xie, L. Stephens, C. A. Thorne, K. Kim, J. Hu, E. Lee, L. Marnett, A. K. Hatzopoulos, and T. P. Zhong., Chemistry & Biology, 2011, 18, 1658.

“Location of inhibitor binding sites in the human inducible prostaglandin E synthase, MPGES1” Prage E. Pawelzik S-C, Busenlehner L. S, Kim K, Morgenstern R, Jakobsson P, Armstrong R. N, Biochemistry, 2011, 50, 7684.

"Small molecule inhibition of Wnt signaling through activation of Casein Kinase 1 alpha” Thorne, C.; Hanson, A.; Schneider, J.; Tahinci, E.; Orton, D.; Cselenyi, C.; Jernigan, K.; Meyers, K.; Hang, B.; Waterson, A.; Kim, K.; Melancon, B.; Ghidu, V.; Sulikowski, G.A.; LaFleur, B.; Salic, A.; Lee, L.; Miller III, D. Nature Chem. Bio., 2010 829.

“Design, Synthesis, and Biological Evaluation of Halogenated N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor” Lavieri, R.R.; Scott, S.A.; Selvy, P.E.; Kim, K.; Jadhav, S.; Morrison, R. D.; Daniels, J.S.; Brown, H.A.; Lindsley, C.W. J. Med. Chem. 2010, 53, 6706.

“Small Molecule Screen Identifies Inhibitors of the Neuronal K-Cl Cotransporter KCC2” Delpire, E.; Days, E.; Lewis, M.; Mi, D.; Kim, K.; Lindsley, C.W.; Weaver, D. PNAS, 2009, 106, 5383.

“Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity” Marlo, J.E; Niswender, C.M; Days, E.L.; Bridges, T.M.; Xiang, Y.; Rodriguez, A.L.; Shirey, J.K.; Brady, A.E.; Nalywajko, T.; Luo, Q.; Austin, C.A.; Williams, M.B.; Kim, K.; Williams, R.; Orton, D.; Brown, H.A.; Lindsley, C.W.; Weaver, C.D.; Conn, P.J. Mol. Pharmacol. 2009, 75(3), 577.

“Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties” Bridges,T.M.; Brady, A.E.; Kennedy, J.P.; Daniels, R.N.; Miller, N.R.; Kim, K.; Breininger, M.L.; Gentry, P.R.; Brogan, J.T.; Jones, C.K.; Conn, P.J.; Lindsley, C.W. Bioorg. Med. Chem. Lett. 2008, 18, 5439.

“Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-b]pyrimidines as novel mGluR4 positive allosteric modulators” Niswender, C.M.; Lebois, E.P.; Luo, C.; Johnson, K.A.M.; Kim, K.; Muchalski, H.; Yin, H.; Conn, P.J.; Lindsley, C.W. Bioorg. Med. Chem. Lett. 2008, 18, 5626.

“An improved synthetic route to labeling precursors for the D2/3 PET agent 18F-fallypride” Kim, K.; Miller, N.R.; Sulikowski, G.A.; Lindsley, C.W. Bioorg. Med. Chem. Lett. 2008, 18, 4467.

“Microwave-assisted protocols for the expedited synthesis of pyrazolo[1,5-a] and [3,4-d]pyrimidines” Daniels, R.N.; Kim, K.; Lebois, E.P.; Muchalski, H.; Hubert, M.; Lindsley, C. W. Tetrahedron Lett. 2008, 49, 305.